MK-1064

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1064, covering 2015-12-10 to 2016-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001) [Phase 1]